首页> 外国专利> DIAGNOSTIC COMPOSITION OF ALZHEIMER'S DISEASE SEVERITY COMPRISING AGENTS MEASURING EXPRESSION LEVEL OF TAU PROTEIN AND DIAGNOSTICS METHOD OF ALZHEIMER'S DISEASE SEVERITY USING THE SAME

DIAGNOSTIC COMPOSITION OF ALZHEIMER'S DISEASE SEVERITY COMPRISING AGENTS MEASURING EXPRESSION LEVEL OF TAU PROTEIN AND DIAGNOSTICS METHOD OF ALZHEIMER'S DISEASE SEVERITY USING THE SAME

机译:含tau蛋白表达水平的阿尔希氏病严重程度的诊断组成及用相同方法诊断阿尔希氏病严重度的诊断方法

摘要

The present invention relates to a composition for diagnosing the disease severity of Alzheimer′s disease comprising tau proteins and a method of diagnosing the disease severity of Alzheimer′s disease using the same. More specifically, p-tau proteins contained in the composition for diagnosing the disease severity of Alzheimer′s disease according to the present invention show a significant increase in severe Alzheimer′s patients compared to an age-matched control group and to mild Alzheimer′s patients; a p-tau content ratio with respect to t-pau content shows a significant increase in mild Alzheimer′s patients as compared to an age-matched control group; a ratio of pSer202 and pThr205 to the t-tau content in severe Alzheimer′s patients shows a substantial increase as compared to mild Alzheimer′s patients; and a ratio of pThr181 to the t-tau content in severe Alzheimer′s patients shows a substantial increase as compared to an age-matched control group. Accordingly, the composition may be beneficially used to efficiently diagnose the disease severity of Alzheimer′s disease.
机译:本发明涉及用于诊断阿尔茨海默氏病疾病严重性的组合物,其包含tau蛋白,以及使用该组合物诊断阿尔茨海默氏病疾病严重性的方法。更具体地,与年龄匹配的对照组和轻度的阿尔茨海默氏病相比,根据本发明的用于诊断阿尔茨海默氏病的疾病严重性的组合物中包含的p-tau蛋白显示出严重阿尔茨海默氏病患者的显着增加。耐心;与年龄匹配的对照组相比,相对于t-pau含量的p-tau含量比率显示轻度阿尔茨海默氏病患者的显着增加;与轻度阿尔茨海默氏症患者相比,重度阿尔茨海默氏症患者中pSer202和pThr205与t-tau含量的比率显着增加;与年龄匹配的对照组相比,重度阿尔茨海默氏症患者的pThr181与t-tau含量之比显示出显着增加。因此,该组合物可以有益地用于有效诊断阿尔茨海默氏病的疾病严重性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号